The association of liver transaminase activity with presence and severity of premature coronary artery disease

Angiology

Volumn 62, Issue 8, 2011, Pages 614-619

  Masoudkabir, Farzad ^a   Karbalai, Shahrokh ^b   Vasheghani Farahani, Ali ^c   Aliabadi, Leila Lak ^a   Boroumand, Mohammad Ali ^c   Aiatollahzade Esfahani, Farah ^c   Pashing, Mina ^c   Hakki, Elham ^c   Goodarzynejad, Hamidreza ^c   Saadat, Soheil ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

angiography; atherosclerosis; liver transaminases; metabolic syndrome; premature coronary artery disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PREMATURE CORONARY ARTERY DISEASE; RISK FACTOR; SCORING SYSTEM;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BODY MASS INDEX; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 80054753935     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711405312     Document Type: Article

References (37)

1. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation. 2001 ; 103 (22). 2705-2710 (Pubitemid 32538786)
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 ; 106 (25). 3143-3421
3. Cole JH, Sperling LS. Premature coronary artery disease: clinical risk factors and prognosis. Curr Atheroscler Rep. 2004 ; 6 (2). 121-125 (Pubitemid 38914956)
4. Sattar N, Scherbakova O, Ford I, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes. 2004 ; 53 (11). 2855-2860 (Pubitemid 39425910)
5. Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB. Haffner SM. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2007 ; 30 (7). 1819-1827 (Pubitemid 47036358)
6. Hanley AJ, Williams K, Festa A, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004 ; 53 (10). 2623-2632 (Pubitemid 39299271)
7. Steinvil A, Shapira I, Ben-Bassat OK, et al. The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol. 2010 ; 9: 30
8. Kawamoto R, Tabara Y, Kohara K, et al. High-sensitivity c-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovasc Diabetol. 2010 ; 9 (1). 87
9. Schindhelm RK, Diamant M, Bakker SJ, et al. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. Eur J Clin Invest. 2005 ; 35 (6). 369-374 (Pubitemid 40826835)
10. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol. 2005 ; 25 (5). 1045-1050 (Pubitemid 40627853)
11. Wang CC, Lin SK, Tseng YF, et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009 ; 24 (8). 1411-1416
12. Eroglu S, Sade LE, Polat E, Bozbas H, Ulus T, Muderrisoglu H. Association between serum gamma-glutamyltransferase activity and carotid intima-media thickness. Angiology. 2011 ; 62 (2). 107-110
13. Pompella A, Emdin M, Paolicchi A, Franzini M. Serum gamma- glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. Angiology. 2011 ; 62 (2). 105-106
14. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis. 2007 ; 191 (2). 391-396 (Pubitemid 46400701)
15. Emdin M, Passino C, Michelassi C, Donato L, Pompella A, Paolicchi A. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. Int J Cardiol. 2009 ; 136 (1). 80-85
16. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005 ; 112 (14). 2130-2137 (Pubitemid 41475806)
17. Adibi P, Sadeghi M, Mahsa M, Rozati G, Mohseni M. Prediction of coronary atherosclerotic disease with liver transaminase level. Liver Int. 2007 ; 27 (7). 895-900 (Pubitemid 47261942)
18. Tong W, Lai H, Yang C, Ren S, Dai S, Lai S. Age, gender and metabolic syndrome-related coronary heart disease in U.S. adults. Int J Cardiol. 2005 ; 104 (3). 288-291 (Pubitemid 41375588)
19. Sadeghian S, Darvish S, Salimi S, et al. Metabolic syndrome: stronger association with coronary artery disease in young men in comparison with higher prevalence in young women. Coron Artery Dis. 2007 ; 18 (3). 163-168 (Pubitemid 46608492)
20. Acikel M, Sunay S, Koplay M, Gundogdu F, Karakelleoglu S. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg. 2009 ; 9 (4). 273-279
21. Athyros VG, Tziomalos K, Gossios TD, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet. 2010 ; 376 (9756). 1916-1922
22. Bader T. Liver tests are irrelevant when prescribing statins. Lancet. 2010 ; 376 (9756). 1882-1883
23. Bergmeyer HU, Horder M, Rej R. International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem. 1986 ; 24 (7). 481-495 (Pubitemid 16058696)
24. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 ; 42 (6). 1206-1252 (Pubitemid 37553153)
25. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 ; 285 (19). 2486-2497
26. Hubert HB, Holford TR, Kannel WB. Clinical characteristics and cigarette smoking in relation to prognosis of angina pectoris in Framingham. Am J Epidemiol. 1982 ; 115 (2). 231-242 (Pubitemid 12182302)
27. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983 ; 51 (3). 606 (Pubitemid 13187192)
28. Saely CH, Vonbank A, Rein P, et al. Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis. Clin Chim Acta. 2008 ; 397 (1-2). 82-86
29. Rejeb J, Omezzine A, Boumaiza I, et al. Elevated liver enzymes in metabolic syndrome are associated with coronary stenosis in a Tunisian population. Metab Syndr Relat Disord. 2010 ; 8 (3). 249-254
30. Marchesini G, Avagnina S, Barantani EG, et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 2005 ; 28 (4). 333-339 (Pubitemid 43162752)
31. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005 ; 54 (11). 3140-3147 (Pubitemid 43334367)
32. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340 (2). 115-126
33. Kerner A, Avizohar O, Sella R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2005 ; 25 (1). 193-197 (Pubitemid 40054275)
34. Lee DH, Jacobs DR. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis. 2005 ; 178 (2). 327-330
35. Yamada J, Tomiyama H, Yambe M, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006 ; 189 (1). 198-205 (Pubitemid 44441282)
36. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology. 2002 ; 35 (4). 898-904 (Pubitemid 34258385)
37. Gianturco SH, Bradley WA. Lipoprotein-mediated cellular mechanisms for atherogenesis in hypertriglyceridemia. Semin Thromb Hemost. 1988 ; 14 (2). 165-169